Gary N. Gross - Concepedia

Author

Gary N. Gross

Research Triangle Park Foundation

Also Known As

G GROSS, G Gross, G N Gross, G. Gross, G.N. Gross, GARY GROSS, GARY N. GROSS, Gary Gross, Gary N Gross, Gary N. Gross

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation University of Colorado Denver National Jewish Health California Allergy and Asthma Medical Group Allergy and Asthma Medical Group and Research Center

About

Gary N. Gross is an author at Research Triangle Park Foundation specializing in medicine, asthma, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	28	2.2K
2	Allergy	13	13	861
3	Natural Sciences	1	1	18
4	Public Health	1	1	71
5	Social Sciences	1	1	132

Gary N. Gross

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial Mani S. Kavuru, Julian Melamed, Gary N. Gross, Journal of Allergy and Clinical Immunology AsthmaAllergy MedicineMedicineAllergenFluticasone Propionate	2000	240
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial John A. Smith, Michael M. Kitt, Alyn H. Morice, The Lancet Respiratory Medicine AsthmaPulmonary CarePhase 2BPharmacologyUnexplained Chronic Cough	2020	216
Omalizumab improves asthma-related quality of life in patients with severe allergic asthma Albert F. Finn, Gary N. Gross, Julius van Bavel, Journal of Allergy and Clinical Immunology AsthmaTranslational MedicineAllergyAllergy MedicineAsthma-related Quality	2003	172
Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center study Donald P. Tashkin, Ashutosh Kumar, Eugene R. Bleecker, The American Journal of Medicine Advanced Lung DiseasePharmacologyPulmonary PharmacologyPulmonary MedicinePharmacotherapy	1986	157
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus Ulrich R. Hengge, W. Kŕause, Heidelore Hofmann, British Journal of Dermatology	2006	138
Early bacterial clearance from murine lungs. Species-dependent phagocyte response. S R Rehm, Gary N. Gross, Alan K. Pierce Journal of Clinical Investigation InflammationInflammatory Lung DiseaseMicrobial PathogensLung InflammationMedicine	1980	134
PARTICIPATION OF INHIBITORY AND EXCITATORY INTERNEURONES IN THE CONTROL OF HIPPOCAMPAL CORTICAL OUTPUT Per Andersen, Gary N. Gross, O. Sveen NeurodynamicsNeurophysiologyMedicineSynaptic TransmissionNeural Circuits	1969	132
Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 μg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 μg, for the Treatment of Moderate Asthma Gary N. Gross, Philip J. Thompson, Paul Chervinsky, CHEST Journal AsthmaMedicinal ChemistryChlorofluorocarbon Beclomethasone DipropionateAllergyHydrofluoroalkane-134a Beclomethasone Dipropionate	1999	127
The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. Galen B. Toews, Gary N. Gross, Alan K. Pierce PubMed Inflammatory Lung DiseaseMicrobial PathogensLung InflammationKlebsiella PneumoniaeImmunology	1979	126
The effect of complement depletion on lung clearance of bacteria. Gary N. Gross, S R Rehm, Alan K. Pierce Journal of Clinical Investigation	1978	117

Page 1